289 related articles for article (PubMed ID: 28943192)
1. Preoperative Factors That Predict the Need to Morcellate in Total Laparoscopic Hysterectomy.
Wolfe M; Biest S; Tutlam N; Woolfolk C; Winner B
J Minim Invasive Gynecol; 2018 Jan; 25(1):158-162. PubMed ID: 28943192
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors of the need to morcellate in total laparoscopic hysterectomy.
Asgari Z; Enzevaei A; Hosseini R; Behnia-Willison F
Aust N Z J Obstet Gynaecol; 2021 Oct; 61(5):759-764. PubMed ID: 34060074
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional transvaginal sonographic assessment of uterine volume as preoperative predictor of need to morcellate in women undergoing laparoscopic hysterectomy.
Gerges B; Mongelli M; Casikar I; Bignardi T; Condous G
Ultrasound Obstet Gynecol; 2017 Aug; 50(2):255-260. PubMed ID: 27281513
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Morcellation Techniques at the Time of Laparoscopic Hysterectomy and Myomectomy.
Meurs EAIM; Brito LG; Ajao MO; Goggins ER; Vitonis AF; Einarsson JI; Cohen SL
J Minim Invasive Gynecol; 2017; 24(5):843-849. PubMed ID: 28483536
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 30-day Complication Rates between Laparoscopic Myomectomy and Total Laparoscopic Hysterectomy for the Treatment of Uterine Leiomyoma in Women Older Than Age 40.
Sheyn D; Bretschnieder CE; Mahajan ST; El-Nashar S; Billow M; Ninivaggio CS
J Minim Invasive Gynecol; 2019; 26(6):1076-1082. PubMed ID: 30385429
[TBL] [Abstract][Full Text] [Related]
6. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
7. Predictive Factors for Morcellation during Total Laparoscopic Hysterectomy: A Cohort Study.
Bergeron C; Laberge PY; Lemyre M; Labrosse S; Maheux-Lacroix S
J Obstet Gynaecol Can; 2023 Aug; 45(8):569-573. PubMed ID: 37211086
[TBL] [Abstract][Full Text] [Related]
8. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
9. What determines the need to morcellate the uterus during total laparoscopic hysterectomy?
Condous G; Bignardi T; Alhamdan D; Van Calster B; Van Huffel S; Timmerman D; Lam A
J Minim Invasive Gynecol; 2009; 16(1):52-5. PubMed ID: 18996059
[TBL] [Abstract][Full Text] [Related]
10. Fibroid morcellation: a shared clinical decision tool for mode of hysterectomy.
Hur HC; King LP; Klebanoff MJ; Hur C; Ricciotti HA
Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():122-127. PubMed ID: 26520875
[TBL] [Abstract][Full Text] [Related]
11. Power morcellation for women undergoing laparoscopic supracervical hysterectomy - safety of procedure and clinical experience from 426 cases.
Rechberger T; Miotła P; Futyma K; Ziętek A; Filipczak A; Rechberger E; Szumiło J; Adamiak-Godlewska A
Ginekol Pol; 2016; 87(8):546-51. PubMed ID: 27629127
[TBL] [Abstract][Full Text] [Related]
12. Complication rate of uterine morcellation in laparoscopic supracervical hysterectomy: a retrospective cohort study.
Smits RM; De Kruif JH; Van Heteren CF
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():179-82. PubMed ID: 26943477
[TBL] [Abstract][Full Text] [Related]
13. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
Harris JA; Swenson CW; Uppal S; Kamdar N; Mahnert N; As-Sanie S; Morgan DM
Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
[TBL] [Abstract][Full Text] [Related]
14. Uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation.
Tan-Kim J; Hartzell KA; Reinsch CS; O'Day CH; Kennedy JS; Menefee SA; Harrison TA
Am J Obstet Gynecol; 2015 May; 212(5):594.e1-10. PubMed ID: 25499259
[TBL] [Abstract][Full Text] [Related]
15. Minilaparotomy Versus Laparoscopic Myomectomy After Cessation of Power Morcellation: Rate of Wound Complications.
Dubin AK; Wei J; Sullivan S; Udaltsova N; Zaritsky E; Yamamoto MP
J Minim Invasive Gynecol; 2017; 24(6):946-953. PubMed ID: 28552622
[TBL] [Abstract][Full Text] [Related]
16. Safety of Manual Morcellation After Vaginal or Laparoscopic-assisted Vaginal Hysterectomy.
Balgobin S; Maldonado PA; Chin K; Schaffer JI; Hamid CA
J Minim Invasive Gynecol; 2016; 23(4):542-7. PubMed ID: 26802908
[TBL] [Abstract][Full Text] [Related]
17. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.
Multinu F; Casarin J; Hanson KT; Angioni S; Mariani A; Habermann EB; Laughlin-Tommaso SK
JAMA Surg; 2018 Jun; 153(6):e180141. PubMed ID: 29641835
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
[TBL] [Abstract][Full Text] [Related]
19. Unexpected uterine sarcomas in 4478 patients with electric power morcellation for leiomyomas.
Chen Q; Shi H; Lu W; Lu B
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():85-89. PubMed ID: 30245442
[TBL] [Abstract][Full Text] [Related]
20. Non-malignant Sequelae after Unconfined Power Morcellation.
Zhang HM; Christianson LA; Templeman CL; Lentz SE
J Minim Invasive Gynecol; 2019; 26(3):434-440. PubMed ID: 29783003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
